Correlation Between VectivBio Holding and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both VectivBio Holding and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VectivBio Holding and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VectivBio Holding AG and Akari Therapeutics PLC, you can compare the effects of market volatilities on VectivBio Holding and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VectivBio Holding with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of VectivBio Holding and Akari Therapeutics.
Diversification Opportunities for VectivBio Holding and Akari Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between VectivBio and Akari is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding VectivBio Holding AG and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and VectivBio Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VectivBio Holding AG are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of VectivBio Holding i.e., VectivBio Holding and Akari Therapeutics go up and down completely randomly.
Pair Corralation between VectivBio Holding and Akari Therapeutics
Given the investment horizon of 90 days VectivBio Holding AG is expected to generate 0.71 times more return on investment than Akari Therapeutics. However, VectivBio Holding AG is 1.42 times less risky than Akari Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Akari Therapeutics PLC is currently generating about -0.04 per unit of risk. If you would invest 776.00 in VectivBio Holding AG on October 21, 2024 and sell it today you would earn a total of 909.00 from holding VectivBio Holding AG or generate 117.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 22.83% |
| Values | Daily Returns |
VectivBio Holding AG vs. Akari Therapeutics PLC
Performance |
| Timeline |
| VectivBio Holding |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Akari Therapeutics PLC |
VectivBio Holding and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with VectivBio Holding and Akari Therapeutics
The main advantage of trading using opposite VectivBio Holding and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VectivBio Holding position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| VectivBio Holding vs. Cns Pharmaceuticals | VectivBio Holding vs. ZyVersa Therapeutics | VectivBio Holding vs. Immix Biopharma | VectivBio Holding vs. Hepion Pharmaceuticals |
| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |